Original language | English |
---|---|
Pages (from-to) | 77-89 |
Number of pages | 13 |
Journal | European Journal of Pharmaceutics and Biopharmaceutics |
Volume | 174.2022 |
Issue number | May |
DOIs | |
Publication status | Published - May 2022 |
Bibliographical note
Funding Information:We thank our colleagues at the Research Center Pharmaceutical Engineering, Clara Roblegg, Gerfried Luschin-Ebengreuth as well as the analytical team for their support with the experimental work. This work was funded through the Austrian Research Promotion Agency (FFG) as part of the PolyPrint project (FFG number 872984) within the FEMtech program. RCPE is a K1 COMET Centre within the COMET ? Competence Centers for Excellent Technologies program. The COMET program? is operated by the Austrian Research Promotion Agency (FFG) on behalf of the Federal Ministry for Transport, Innovation and Technology (BMVIT) and the Federal Ministry for Digital and Economic Affairs (BMDW). Our projects are also funded by Land Steiermark and the Styrian Business Development Agency (SFG).
Funding Information:
This work was funded through the Austrian Research Promotion Agency (FFG) as part of the PolyPrint project (FFG number 872984) within the FEMtech program. RCPE is a K1 COMET Centre within the COMET – Competence Centers for Excellent Technologies program. The COMET prograḿ is operated by the Austrian Research Promotion Agency (FFG) on behalf of the Federal Ministry for Transport, Innovation and Technology (BMVIT) and the Federal Ministry for Digital and Economic Affairs (BMDW). Our projects are also funded by Land Steiermark and the Styrian Business Development Agency (SFG).
Publisher Copyright:
© 2022 Elsevier B.V.
Keywords
- Acyclovir
- Combination product
- Controlled drug release
- Customization
- Fused filament fabrication
- Incontinence
- Thermoplastic polyurethane